Balyasny Asset Management
SPRY icon

Balyasny Asset Management’s ARS Pharmaceuticals SPRY Stock Holding History

Balyasny Asset Management’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$496K Buy
+61,752
New +$592K ﹤0.01% 2367
2025
Q4 		– Sell
-246,170
Closed -$2.47M – 3521
2025
Q3 		$2.47M Sell
246,170
-82,903
-25% -$1.19M ﹤0.01% 1704
2025
Q2 		$5.74M Buy
329,073
+157,949
+92% +$2.28M 0.01% 1218
2025
Q1 		$2.15M Sell
171,124
-173,817
-50% -$2.09M ﹤0.01% 1672
2024
Q4 		$3.64M Buy
344,941
+322,423
+1,432% +$4.52M 0.01% 1419
2024
Q3 		$327K Sell
22,518
-3,817
-14% -$45.4K ﹤0.01% 2431
2024
Q2 		$224K Sell
26,335
-4,106
-13% -$36.4K ﹤0.01% 2308
2024
Q1 		$311K Buy
30,441
+13,002
+75% +$96.9K ﹤0.01% 2245
2023
Q4 		$95.6K Buy
+17,439
New +$76.4K ﹤0.01% 2386
2023
Q1 		– Sell
-11,328
Closed -$96.6K – 3118
2022
Q4 		$96.6K Buy
+11,328
New +$73.5K ﹤0.01% 2255

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return